利图西马布在淋巴结膜炎的使用:有什么证据?
Wenjuan Zhu1, Haiyan He1, Pearl Pai1,2
1Department of Nephrology, University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, China.
Biomedicines
|September 27, 2025
概括
利图西马布是治疗淋巴结膜炎的关键治疗方法,包括初级膜性脏病和ANCA相关的血管炎. 需要对其剂量,再剂量和长期安全性进行进一步的研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 利图西马布越来越多地用于各种丸炎治疗.
- 目前的KDIGO指南建议Rituximab作为一线治疗原发性膜性病和ANCA相关的血管炎.
研究的目的:
- 审查证据支持Rituximab在淋巴结膜炎的使用.
- 为了确定当前Rituximab应用中的缺陷,包括剂量和安全性.
- 为患者管理提供实际指导.
主要方法:
- 最近证据和临床指南的文献综述.
- 关于利图西马布在球炎中的疗效和安全性的研究分析.
- 综合有关剂量,再剂量和长期结果的信息.
主要成果:
- 利图西马布已被确立为特定类型的淋巴结膜炎的第一线治疗.
- 在了解最佳剂量和再剂量策略方面存在差距.
- 长期安全数据需要进一步调查.
结论:
- 利图西马布是几种丸炎疾病的有价值的治疗选择.
- 进一步的研究对于优化利图西马布的使用和确保患者安全至关重要.
- 提供了实用提示,以帮助临床医生在患者管理.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
492
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
492
Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
190
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
190


